Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers October 21, 2014
Pharmacy Choice - News - Over-the-Counter Drugs - October 21, 2014

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 31     Next >>     Go To Page:

10/21/14 - NAFDAC, counterfeiting and public health [Sun, The (Nigeria)]
Sometime in 2005, a friend took ill at workplace in one of the federal parastatals in Lagos and had to visit the Staff Clinic. An experienced doctor after thoroughly examining him put his finger on the cause of his sickness by correctly diagnosing malaria. The doctor prescribed an anti-malaria drug, Halfan, for treatment and because the medicine wa
10/21/14 - Report: Actavis, Sanofi To Bid On Over-The-Counter Drug Maker
Bloomberg, citing unnamed sources, said Omega could be worth up to $5.1 billion, with final offers expected next month. Also bidding are Perrigo Co. plc and privately held Boehringer Ingelheim, according to Bloomberg. Privately held Omega had $166 million in revenue for the first six months of 2014, up 60 percent from a year earlier, Bloomberg said
10/20/14 - GNW-News: Novartis announces FDA Advisory Committee unanimously recommends approval of AIN457 (secukinumab) for patients with moderate-to-severe plaque psoriasis (english)
Novartis announces FDA Advisory Committee unanimously recommends approval of AIN457 for patients with moderate-to-severe plaque psoriasis. Novartis International AG/ Novartis announces FDA Advisory Committee unanimously recommends approval of AIN457 for patients with moderate-to-severe plaque psoriasis. 17 A inhibitor, is currently under FDA...
10/20/14 - NAFDAC, Counterfeiting and Public Health [opinion]
SOMETIME in 2005, a friend took ill at workplace in one of the federal parastatals in Lagos and had to visit the staff clinic. An experienced doctor after thoroughly examining him put his finger on the cause of his sickness by correctly diagnosing malaria. The doctor prescribed an anti-malaria drug for treatment and because the medicine was out of
10/20/14 - North America Pharmaceutical Packaging Market Outlook 2019 - Major Vendors for the $26 Billion Industry are Amcor, CCL Industries, Intrapac, Rexam...
North America Pharmaceutical Packaging Market Outlook 2019- Major Vendors for the $26 Billion Industry are Amcor, CCL Industries, Intrapac, Rexam Plc and Schott AG. By a News Reporter-Staff News Editor at Pharma Business Week Research and Markets has announced the addition of the "North America Pharmaceutical Packaging Market- By Primary Packagin
10/20/14 - Novartis announces FDA Advisory Committee unanimously recommends approval of AIN457 (secukinumab) for patients with moderate-to-severe plaque psoriasis
There is a need for novel therapies as not all treatments are appropriate or effective in every patient, "said Vas Narasimhan, Global Head Development, Novartis Pharmaceuticals. We look forward to working with the FDA as it finalizes its review. " In these studies, secukinumab met all primary and key secondary endpoints, including Psoriasis Area an
10/20/14 - Pinney Associates, Inc. Celebrates 20th Anniversary
Pinney Associates, Inc. celebrates 20 years of helping consumer healthcare and pharmaceutical companies to make science-based decisions for the betterment of public health. Founded in 1994 by John Pinney, today Pinney Associates is a consulting leader in prescription to over-the-counter switch, the support of marketed consumer healthcare products
10/20/14 - Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer
Taiho Oncology, Inc., a subsidiary of Taiho Pharmaceutical Co., Ltd., announced that the U.S. Food and Drug Administration granted Fast Track designation for TAS-102, an oral combination anticancer drug under investigation for the treatment of refractory metastatic colorectal cancer, and that the Company has initiated a rolling NDA submission to
10/20/14 - Takeda and Orexigen Announce Availability of CONTRAVE (naltrexone HCI and bupropion HCI) Extended-Release Tablets for Chronic Weight Management in Obese Adults
DEERFIELD, Ill. and OSAKA, Japan, Oct. 20, 2014/ PRNewswire/ Takeda Pharmaceutical Company Limited, its wholly-owned subsidiary Takeda Pharmaceuticals U.S.A., Inc. and Orexigen Therapeutics, Inc. jointly announced today that Contrave extended-release tablets are now available to patients by prescription in pharmacies across the United State
10/20/14 - WALGREEN CO - 10-K - Management's Discussion and Analysis of Financial Condition and Results of Operations
Factors that might cause a difference include, but are not limited to, those discussed under "Cautionary Note Regarding Forward-Looking Statements" below and in Item 1 A of this Form 10- K. References herein to " Walgreens," the "Company," "we," "us" or "our" refer to Walgreen Co. and its subsidiaries included in the consolidated financial statemen
10/19/14 - AnthroTronix Receives FDA Clearance for Brain Health Assessment Tool [EMBIN (Emerging Markets Business Information News]
? ?We are pleased that DANA has sought and received FDA clearance, leading the way for this type of game-changing technology, ? said Corinna Lathan, founder and CEO of AnthroTronix. ? ?In essence, measuring reaction time is like taking the temperature of the brain? like a' Brain Thermometer'? and it is a vital par
10/19/14 - Nielsen Catalina Solutions and Crossix Deliver Breakthrough Television Solution for Pharma [EMBIN (Emerging Markets Business Information News]
Nielsen Catalina Solutions, a leader in behavior-based TV planning and analytics, and Crossix Solutions, the leader in healthcare marketing analytics, have announced a new collaboration that will enable pharma advertisers and their media agencies to improve how they plan and optimize TV media campaigns. ? ?AdVantics Rx is a game changer for th
10/19/14 - OTC Daily Alert Stock Watch - Acura Pharmaceuticals, Inc., (NASDAQ: ACUR)
Today's alerts include: Acura Pharmaceuticals, Inc.,; FRIDAY CLOSE$. 58. Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, researches, develops, and commercializes products to address medication abuse and misuse utilizing its proprietary Aversion and Impede technologies. Acura Pharmaceuticals, Inc. was founded in 1935 and is based in
10/19/14 - OTC Daily Alert Stock Watch - Adamas Pharmaceuticals, Inc., (NASDAQ: ADMS)
Today's alerts include: Adamas Pharmaceuticals, Inc.,; FRIDAY CLOSE $14.54. Adamas Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems in the United States. Adamas Pharmaceuticals, Inc. was founded in 2000 and is...
10/19/14 - OTC Daily Alert Stock Watch - Adamis Pharmaceuticals Corporation (NASDAQ: ADMP)
New York, NY October 19, 2014 OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Today's alerts include: Adamis Pharmaceuticals Corporation; FRIDAY CLOSE $4.11. Adamis Pharmaceuticals Corporation, a biopharmaceutical company, is engaged in the development and commercialization of specialty pharmaceutical a
10/19/14 - OTC Daily Alert Stock Watch - Aradigm Corporation (NASDAQ: ARDM)
Today's alerts include: Aradigm Corporation; FRIDAY CLOSE $8.18. Aradigm Corporation, a specialty pharmaceutical company, focuses on the development and commercialization of drugs delivered by inhalation for the treatment and prevention of respiratory diseases by pulmonologists. Aradigm Corporation was founded in 1991 and is headquartered in Haywar
10/19/14 - OTC Daily Alert Stock Watch - Delcath Systems, Inc. (NASDAQ: DCTH)
Today's alerts include: Delcath Systems, Inc.; FRIDAY CLOSE $1.74. Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on the field of oncology in the United States and internationally. Delcath Systems, Inc. was founded in 1988 and is headquartered in New York, New York.
10/19/14 - OTC Daily Alert Stock Watch - Flamel Technologies SA, (NASDAQ: FLML)
Today's alerts include: Flamel Technologies SA,; FRIDAY CLOSE $12.19. Flamel Technologies SA, a specialty pharmaceutical company, develops and commercializes pharmaceutical products based on its proprietary polymer based technology. Flamel Technologies SA was founded in 1990 and is headquartered in Vnissieux, France.
10/19/14 - OTC Daily Alert Stock Watch - Intellipharmaceutics International Inc. (NASDAQ: IPCI)
Today's alerts include: Intellipharmaceutics International Inc.; FRIDAY CLOSE $2.74. Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled and targeted release oral solid dosage drugs in Canada. Intellipharmaceutics International Inc. is headquartered in Toronto,...
10/17/14 - NAFDAC, Counterfeiting and Public Health [opinion]
Sometime in 2005, a friend took ill at workplace in one of the federal parastatals in Lagos and had to visit the Staff Clinic. An experienced doctor after thoroughly examining him put his finger on the cause of his sickness by correctly diagnosing malaria. The doctor prescribed an anti-malaria drug, Halfan, for treatment and because the medicine wa
10/16/14 - AnthroTronix Receives FDA Clearance for Brain Health Assessment Tool
AnthroTronix, a research and development company that designs health technology, announced today it has received U.S. Food and Drug Administration clearance for its computerized cognitive test battery known as DANA?. We are pleased that DANA? has sought and received FDA clearance, leading the way for this type of game-changing technology,
10/16/14 - Nielsen Catalina Solutions and Crossix Deliver Breakthrough Television Solution for Pharma
Nielsen Catalina Solutions, a leader in behavior-based TV planning and analytics, and Crossix Solutions, the leader in healthcare marketing analytics, have announced a new collaboration that will enable pharma advertisers and their media agencies to improve how they plan and optimize TV media campaigns. NCS AdVantics Rx, powered by Crossix, will
10/16/14 - Patent Application Titled "Systems and Methods for Providing an Inducement to Purchase Incident to a Physician'S Prescription of Medication"...
Patent Application Titled "Systems and Methods for Providing an Inducement to Purchase Incident to a Physician'S Prescription of Medication" Published Online. By a News Reporter-Staff News Editor at Politics& Government Week According to news reporting originating from Washington, D.C., by VerticalNews journalists, a patent application by the inv
10/16/14 - Perrigo Enters New Therapeutic Category With The Acquisition Of Women's Health Product Portfolio From Lumara Health
By a News Reporter-Staff News Editor at Women's Health Weekly Perrigo Company plc announced that it has signed a definitive agreement to acquire a portfolio of women's healthcare products from Lumara Health, Inc., a privately-held, Chesterfield, Missouri- based specialty pharmaceutical company, for $82 million in cash. Perrigo Chairman, President
10/15/14 - FDA Approves Esbriet (pirfenidone) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) in the United States
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has approved Esbriet as a treatment for idiopathic pulmonary fibrosis in the United States. This is a historic day for the people and their families in the United States who live with this deadly, incurable disease, said Sandra Horning, M.D.,
Articles(s): 1 - 25 of 31     Next >>     Go To Page:


© 2014 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

The Diversion of Controlled Substances and the Law
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415